ARS Pharmaceuticals, Inc. Accrued Liabilities, Current
ARS Pharmaceuticals, Inc. (SPRY) had Accrued Liabilities, Current of $3.65 million as of 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-02
- 2022-09-30: Accrued Liabilities, Current $3.65M.
- 2022-06-30: Accrued Liabilities, Current $8.15M.
- 2022-03-31: Accrued Liabilities, Current $11.05M.
- 2021-12-31: Accrued Liabilities, Current $11.73M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2022-09-30 | $3.65M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $8.15M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.05M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $11.73M 10-Q · filed 2022-11-02 |
| 2021-09-30 | $12.54M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $12.79M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.80M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $5.28M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |